Progress in the treatment of central serous chorioretinopathy
10.3980/j.issn.1672-5123.2016.11.18
- VernacularTitle:中心性浆液性脉络膜视网膜病变治疗方法的研究进展
- Author:
Yuan-Lu, SHUAI
;
Wang-Yi, FANG
;
Song-Tao, YUAN
- Publication Type:Journal Article
- Keywords:
central serous chorioretinopathy;
treatment;
review
- From:
International Eye Science
2016;16(11):2059-2062
- CountryChina
- Language:Chinese
-
Abstract:
Central serous chorioretinopathy( CSC) is an important cause for central vision loss. It mostly occurs in young and middle-aged men. It is a condition characterized by a serous detachment of neurosensory retina at the posterior pole and leakage from the retinal pigment epithelium ( RPE ) . Most patients with acute CSC will resolve spontaneously. However, in cases of chronic CSC with persistent serous retinal detachment, patients might develop progressive vision loss. This article was made a brief review of the current treatment methods, including laser, photodynamic therapy ( PDT ) , intravitreal anti-vascular endothelial growth factor therapy and the mineralocorticoid receptor antagonists.
